Arrowpoint Asset Management LLC 13D and 13G filings for TCR2 Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 1:29 pm Sale |
2020-12-31 | 13G | TCR2 Therapeutics Inc. TCRR |
Arrowpoint Asset Management LLC | 1,167,220 3.500% |
-102,546 (-8.08%) |
Filing |